Chemesis International Inc. - günstige Cannabis-Aktie (Seite 11)
eröffnet am 05.09.18 16:13:54 von
neuester Beitrag 06.03.24 18:33:05 von
neuester Beitrag 06.03.24 18:33:05 von
Beiträge: 2.751
ID: 1.287.816
ID: 1.287.816
Aufrufe heute: 0
Gesamt: 352.612
Gesamt: 352.612
Aktive User: 0
ISIN: CA75867L2066 · WKN: A407GC · Symbol: RUU
0,0950
CAD
+5,56 %
+0,0050 CAD
Letzter Kurs 22.04.24 CSE
Neuigkeiten
01.03.24 · globenewswire |
27.02.24 · globenewswire |
10.02.24 · globenewswire |
08.02.24 · globenewswire |
Werte aus der Branche Rohstoffe
Wertpapier | Kurs | Perf. % |
---|---|---|
0,7950 | +30,33 | |
55,80 | +15,41 | |
0,7999 | +14,27 | |
11,250 | +12,73 | |
0,5500 | +10,00 |
Wertpapier | Kurs | Perf. % |
---|---|---|
0,5100 | -8,93 | |
2,1800 | -9,17 | |
186,20 | -10,48 | |
4,2300 | -17,86 | |
46,74 | -98,00 |
Beitrag zu dieser Diskussion schreiben
Kosumieren aus Langeweile 😎
https://www.finanzen.net/nachricht/aktien/corona-profiteure-…
Während immer mehr Menschen aufgrund der Corona-Pandemie zu Hause bleiben, weil sie ihrem Job aktuell nicht nachkommen können, um im Homeoffice zu arbeiten, oder um die Kinder zu betreuen, nahm jenseits des großen Teichs die Nachfrage nach Cannabis zu.
https://www.finanzen.net/nachricht/aktien/corona-profiteure-…
Während immer mehr Menschen aufgrund der Corona-Pandemie zu Hause bleiben, weil sie ihrem Job aktuell nicht nachkommen können, um im Homeoffice zu arbeiten, oder um die Kinder zu betreuen, nahm jenseits des großen Teichs die Nachfrage nach Cannabis zu.
Gibts irgendetwas Neues von Bedeutung?
Antwort auf Beitrag Nr.: 63.026.014 von tzadoz2014 am 16.03.20 15:38:39
Da ist wenigstens kein Stillstand 👌🏽😬
Da ist wenigstens kein Stillstand 👌🏽😬
News
https://www.stockwatch.com/News/Item?bid=Z-C%3aCSI-2878249&s…VANCOUVER, BC / ACCESSWIRE / March 16, 2020 / Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the "Company" or "Chemesis"), announces its Puerto Rico operations will remain operational during the COVID-19 pandemic with adjusted hours.
As per Executive Order No. 2020-023 ("Order"), medical cannabis establishments can continue to grow, manufacture, sell, dispatch or transport medicinal cannabis products to patients across Puerto Rico. To remain compliant under the Order, all Green Spirit Rx. and Caribbean Green dispensaries will have operating hours from 8am to 6pm daily, which will remain in effect until March 30, 2020 or until further notice.
"Chemesis continues to operate under new guidance to ensure patients are able to obtain their medical cannabis," said CEO of Chemesis, Edgar Montero.
Antwort auf Beitrag Nr.: 62.993.681 von tzadoz2014 am 13.03.20 10:24:14
https://www.thegrowthop.com/wellness/people-staying-in-amid-…
😂
Zitat von tzadoz2014: Müssten jetzt nicht eigentlich die Cannabisaktien einen erneuten Boom erleben ? Denn mal ehrlich. Wie soll man diese ganze Scheiße mit dem Coronavirus anders ertragen, als komplett stoned und zugeballert. 😎
https://www.thegrowthop.com/wellness/people-staying-in-amid-…
😂
Müssten jetzt nicht eigentlich die Cannabisaktien einen erneuten Boom erleben ? Denn mal ehrlich. Wie soll man diese ganze Scheiße mit dem Coronavirus anders ertragen, als komplett stoned und zugeballert. 😎
Antwort auf Beitrag Nr.: 62.962.376 von rOllee am 11.03.20 14:24:30
Immerhin mal wieder eine Meldung. Auch wenn es keine ist, die Investierte jubeln lässt.
Zitat von rOllee: https://www.accesswire.com/580094/Chemesis-International-Inc-Announces-Board-Changes-to-GSRX-Industries-Inc
Immerhin mal wieder eine Meldung. Auch wenn es keine ist, die Investierte jubeln lässt.
ich bin am überlegen die aktie zu verkaufen, habe nach dem rs nicht mehr zugelangt, aktueller ek liegt bei ca. 8,50$, verlust von ca. 93%. hab auch keinen bock nachzukaufen, schade ums geld bzw. hab hier eh schon einige tausend euro in den sand gesetzt. kann diese im depot einfach nicht mehr sehen, so kann ich den verlust dann wenigstens steuerlich ausgleichen.
die firma ist total unseriös geworden, schade. mir hat chemesis immer gut gefallen.
die firma ist total unseriös geworden, schade. mir hat chemesis immer gut gefallen.
Kein Kommentar zu den Aufträgen mit Mindestbestellwert. Oder sonst etwas, was einen Anleger wirklich interessieren könnte. Einfach nur "Aussichten bleiben positiv im Jahr 2020".
https://www.stockwatch.com/News/Item?bid=Z-C%3aCSI-2873780&s…
Second Quarter 2020 Financial and Operational Highlights:
Revenue of $944,457, the comparative period of the prior fiscal year generated $2.8 million. The decrease was directly related to the abeyance of licenses held by our subsidiaries, Natural Ventures LLC and GSRX Industries Inc. During this time, the Company has been focused on reinstating its licenses, maintaining its cultivation inventories and reducing its operational burn rates.
Gross profits over the quarter of $1.3 million, representing an increase of $843,000 from the comparative period of the prior fiscal year and an increase of $1.2 million from the most recently completed fourth quarter of the prior fiscal year. This is due to the increase in values arising from cultivation inventory and sales yielding greater margins.
The Company had a cash reserve of $1.3 million at the end of Q2 2020, and has since announced the closing of a $5 million private placement.
The Company saw a net loss of $17 million over the quarter which consists of the following non-cash items, bad debt expense representing the estimated credit loss of receivables, depreciation of assets, share-based payments associated with shares issued and options granted, interest expense on amortization of convertible debt and lease liabilities, loss on investment in GSRX Industries being the decline in the market price of GSRX shares, loss on sale of a building, impairment of California's intangible assets, and impairment of goodwill. These non-cash items contribute over $14.5 million of the Company's net loss.
In addition, The Company's operations in Puerto Rico saw a favourable judgement and received notification that its licensed for all cannabis cultivation and cannabis manufacturing licenses were reinstated on February 3, 2020.
"Chemesis continues to see growth and opportunities that will allow the Company to increase its presence in Puerto Rico, the United States and Colombia," said CEO of Chemesis, Edgar Montero. "The Company continues to concentrate its efforts in building a strong and sustainable operation that is able to thrive in the cannabis market. Chemesis has seen some headwinds but the Company's outlook for calendar 2020 remains positive as there continues to be a focused effort on the bottom-line."
https://www.stockwatch.com/News/Item?bid=Z-C%3aCSI-2873780&s…
Second Quarter 2020 Financial and Operational Highlights:
Revenue of $944,457, the comparative period of the prior fiscal year generated $2.8 million. The decrease was directly related to the abeyance of licenses held by our subsidiaries, Natural Ventures LLC and GSRX Industries Inc. During this time, the Company has been focused on reinstating its licenses, maintaining its cultivation inventories and reducing its operational burn rates.
Gross profits over the quarter of $1.3 million, representing an increase of $843,000 from the comparative period of the prior fiscal year and an increase of $1.2 million from the most recently completed fourth quarter of the prior fiscal year. This is due to the increase in values arising from cultivation inventory and sales yielding greater margins.
The Company had a cash reserve of $1.3 million at the end of Q2 2020, and has since announced the closing of a $5 million private placement.
The Company saw a net loss of $17 million over the quarter which consists of the following non-cash items, bad debt expense representing the estimated credit loss of receivables, depreciation of assets, share-based payments associated with shares issued and options granted, interest expense on amortization of convertible debt and lease liabilities, loss on investment in GSRX Industries being the decline in the market price of GSRX shares, loss on sale of a building, impairment of California's intangible assets, and impairment of goodwill. These non-cash items contribute over $14.5 million of the Company's net loss.
In addition, The Company's operations in Puerto Rico saw a favourable judgement and received notification that its licensed for all cannabis cultivation and cannabis manufacturing licenses were reinstated on February 3, 2020.
"Chemesis continues to see growth and opportunities that will allow the Company to increase its presence in Puerto Rico, the United States and Colombia," said CEO of Chemesis, Edgar Montero. "The Company continues to concentrate its efforts in building a strong and sustainable operation that is able to thrive in the cannabis market. Chemesis has seen some headwinds but the Company's outlook for calendar 2020 remains positive as there continues to be a focused effort on the bottom-line."
01.03.24 · globenewswire · Refined Energy |
01.03.24 · IRW Press · Refined Energy |
27.02.24 · globenewswire · Refined Energy |
10.02.24 · globenewswire · Refined Energy |
08.02.24 · globenewswire · Refined Energy |
27.01.24 · globenewswire · Refined Energy |
29.11.23 · globenewswire · Refined Energy |
13.11.23 · globenewswire · Refined Energy |
26.07.23 · IRW Press · Refined Energy |
26.07.23 · globenewswire · Refined Energy |